Bitdeer Technologies
BTDR
Hut 8
HUT
Riot Platforms
RIOT
Bakkt Holdings
BKKT
Canaan
CAN
US Stock MarketDetailed Quotes
CLDI Calidi Biotherapeutics
- 1.892
- -0.008-0.43%
Trading Dec 12 13:16 ET
36.54MMarket Cap-0.63P/E (TTM)
1.925High1.810Low428.04KVolume1.870Open1.900Pre Close793.03KTurnover2.60%Turnover RatioLossP/E (Static)19.32MShares20.40052wk High-3.22P/B31.14MFloat Cap0.73052wk Low--Dividend TTM16.46MShs Float137.900Historical High--Div YieldTTM6.05%Amplitude0.730Historical Low1.852Avg Price1Lot Size
Calidi Biotherapeutics Key Stats
EPS
According to the latest financial report of Calidi Biotherapeutics, the latest earnings per share (TTM) for the company is -0.65. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Calidi Biotherapeutics's free cash flow? The latest report shows it as -4.95M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Calidi Biotherapeutics shows that the company's current ratio is 0.19, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Calidi Biotherapeutics, the quick ratio is 0.16, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Calidi Biotherapeutics? The latest ROE figure is --, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Calidi Biotherapeutics, the total asset return on investment (ROA) is -77.23%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Calidi Biotherapeutics's latest financial report to see how their gross margin is doing - currently at 87.65%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Calidi Biotherapeutics, the net profit margin is -861.48%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.